27 /100
MEDIUM RISK
Score updated Jul 14, 2026

BALY — Bally's Corporation Dilution Risk Tracker

Track BALY dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BALY — Get alerts when the score changes →

As of July 14, 2026, Bally's Corporation (BALY) has a DilutionWatch DilutionScore of 27/100, rated MEDIUM dilution risk. Bally's Corporation has a market capitalization of $694.09M, 48.95M shares outstanding, 62 institutional holders tracked. Key dilution vectors include 384.5K outstanding warrants, approximately 45 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
60
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BALY.
🔔 Track BALY — Get forecast alerts →

💹 Market Data

Market Cap$694.09M
Shares Outstanding48.95M
Float10.15M
Cash$559.30M
Debt$4.41B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 2.5% shares (2026Q1 vs prior)
62 institutional holders · 38.50M shares
#1 Standard General L.P. 32.48M shares
#2 Whitefort Capital Management, LP 2.41M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 1.06M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest913.1K
Days to Cover9.7
% of Float9.0%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Feb 07, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2023
4 INSIDER TRANSACTION Mar 25, 2026
4 INSIDER TRANSACTION Mar 25, 2026
4 INSIDER TRANSACTION Mar 03, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for BALY Shareholders

Bally's Corporation (BALY) has a DilutionScore of 27/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch tracks 384,536 outstanding warrants for BALY. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for BALY in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for BALY alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track BALY Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BALY — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for BALY
📊 BALY FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BALY Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.